TR-128

N/A

Report date: 2024/06/06 14:45:24
NME

Base Information

Drug NameTR-128
Drug Alias NameTR128TR-128
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGTPase Ras inhibitorsRAF serine/threonine protein kinase inhibitors
TargetsGTPase RasRAF serine/threonine protein kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTarapeutics Science Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A